주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-04-25 16:53 (Thurs)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
Pharma
목록
(
총 :
1,688 )
기사목록 보기 형태
제목형
요약형
포토형
IL-23 inhibitors stage fierce competition in psoriasis, arthritis treatment market
Jeong Min-jun
2023.04.05 13:02
Korea's microbiome industry shows robust growth despite late start, experts say
Marianne Chang
2023.04.05 10:27
CAR-T therapy Kymriah expands indication for follicular lymphoma
Lee Han-soo
2023.04.05 10:22
[Special] Long-waited drugs were approved, but patients must wait for insurance benefits
Kim Yun-mi
2023.04.04 13:01
LG Chem releases diabetes combo, expects insurance coverage in May
Marianne Chang
2023.04.04 10:20
'We are committed to advocating for rare disease patients'
You Ji-young
2023.04.03 16:43
Bukwang launches Korea’s 1st zaleplon-based insomnia drug
Lee Han-soo
2023.04.03 14:38
Sanofi’s Dupixent expands insurance coverage for children and adolescents in Korea
Marianne Chang
2023.04.03 14:02
[Top K-Pharma Analysis ⑩] Analysts paint rosy picture for Cosmax, citing recovery in Chinese demand
Lee Han-soo
2023.03.31 16:49
Aribio’s muscle-strengthening natural ingredient wins MFDS’ individual certification
Jeong Min-jun
2023.03.31 16:07
Zolgensma SMA therapy confirms long-term efficacy for up to 7.5 years
Marianne Chang
2023.03.31 11:41
[GVIRF 2023] The year 2023 is for RSV vaccines, says Johns Hopkins expert
Marianne Chang
2023.03.31 10:23
처음
이전
이전
이전
71
72
73
74
75
76
77
78
79
80
다음
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기